Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.22
+0.01000.83%
Post-market: 1.220.00000.00%16:05 EDT
Volume:212.62K
Turnover:262.41K
Market Cap:60.78M
PE:-1.09
High:1.27
Open:1.19
Low:1.19
Close:1.21
Loading ...

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?

Zacks
·
01 May

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

Business Wire
·
30 Apr

BUZZ-Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks

Reuters
·
30 Apr

Quanterix Revises Merger Terms with Akoya Biosciences

TIPRANKS
·
29 Apr

Akoya Biosciences Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
29 Apr

BRIEF-Quanterix And Akoya Biosciences Announce Amended Merger Agreement

Reuters
·
29 Apr

Quanterix and Akoya Amend Merger Deal Amid Volatility

Dow Jones
·
29 Apr

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

THOMSON REUTERS
·
29 Apr

Quanterix Corp: Under Amended Terms, Co Will Issue About 7.76 Mln Shares of Its Common Stock and Pay $20 Mln in Cash to Akoya Shareholders

THOMSON REUTERS
·
29 Apr

Quanterix Corp - Akoya Shareholders to Receive $0.38 Cash and 0.1461 Quanterix Shares

THOMSON REUTERS
·
29 Apr

Press Release: Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Dow Jones
·
29 Apr

Akoya Biosciences price target lowered to $1.80 from $3.50 at Canaccord

TIPRANKS
·
29 Apr

BRIEF-Akoya Biosciences And Singapore Translational Cancer Consortium (STCC) Partner On Super Study Designed To Advance Cancer Immunophenotyping For Patients In Singapore

Reuters
·
23 Apr

Akoya Biosciences and Singapore Translational Cancer Consortium (Stcc) Partner on Super Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

THOMSON REUTERS
·
23 Apr

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

GlobeNewswire
·
23 Apr

BRIEF-Kent Lake Files Definitive Proxy Statement And Sends Letter To Quanterix Shareholders

Reuters
·
17 Apr

Kent Lake: Urges Quanterix Shareholders to Vote Against Akoya Merger Proposals

THOMSON REUTERS
·
17 Apr

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Business Wire
·
17 Apr

Akoya Biosciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
14 Apr

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

Business Wire
·
07 Apr